Stage IIIB Breast Cancer Active Not Recruiting Phase 2 Trials for Cixutumumab (DB12250)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00684983Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast CancerTreatment